Neogen Chemicals Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/auyb0yb0zxrrnv7ez6e68j2w.pdf

Key Takeaways


Battery Chemicals: Capacity, Approvals & the Non-FEOC Opportunity

Dr. Harin Kanani: "We are currently seeing significant tailwinds from the US 45X tax credits non-FEOC requirements and recent price volatility in China, both of which enhance our appeal as a strategic global partner."

Financial Position: Inflows, Costs & the Balance Sheet


Segment Performance: Inorganic Surge, Organic Steady, CDMO Waiting


Competitive Moat & Customer Dynamics

Dr. Harin Kanani: "I think one is we are already ready. We already have three-four years experience to make it in the lab and supply successfully and last one or two years even from a commercial plant in Dahej. Second, we have Mitsubishi collaboration. Mitsubishi is known to be the best electrolyte producer in terms of quality. So, then you can be 100% sure about the quality of the supply. And the third is we have the backward integration. Fourth is we have actual capacity because one of the thing is you need to have the capacity."

Guidance & Commitments

CommitmentSpecificsTimeline
Dahej replacement plant commissioningFully compliant and optimized facility; partial availability March-April 2026, full by end of June 2026; stable production from Q2 FY27Q1 FY27
Pakhajan commercial productionElectrolyte in H1 FY27; electrolyte salts in H2 FY27; trial salt production by Q2 FY27 (September 2026)H1/H2 FY27
Dahej site audit and approvalSite audited and approved; most capacity online; good salt-related revenues from Q2, Q3, Q4By June 2026
FY27 battery chemicals revenueINR 400 to INR 500 crore; Pakhajan Q4 salt sales not considered, kept as bufferFY27
Base business (organic/inorganic) FY27Double-digit revenue growth expected with Dahej plant coming on track post-fireFY27
Insurance second interim paymentINR 60 crore against rebuildingWithin the week
Insurance main stock claimINR 150–170 croreBefore end of March 2026
Morita investment receipt$20 million from JV partnerEnd of current quarter or possibly April 2026; by Q1 FY27
Promoter preferential issueINR 150 crore equity infusionBefore end of March 2026, subject to regulatory approval; worst case Q1 FY27
Total expected inflowsAround INR 550 crore (insurance + Morita + promoter)Either this year or Q1 FY27
Debt principal repayment startDahej: Q1 FY28; Pakhajan: H1 FY28 (one year from SCOD)FY28
Insurance process completionFull recovery ultimately achievedSeptember to December 2026
Capacity utilization ceilingSalt at 80%; electrolyte up to 100%Steady-state
Dr. Harin Kanani: "I am a little bit more careful. What we have done is that Q4 whatever Pakhajan salt sales we have not considered, if Dahej is slightly delayed or electrolyte is delayed, the Q4 salt sales will allow me to make up for that so that we do not go wrong on our guidance in the next financial year."

Key Metrics

MetricQ3 FY26
Consolidated revenue₹220 cr, 9% YoY growth
Gross profit growth13% YoY, with around 150 bps margin expansion
Organic chemical revenue₹187 cr, 6% YoY growth
Inorganic chemical revenue₹33 cr, 35% YoY growth
Neogen Ionics revenue contribution₹12 cr
EBITDA₹32 cr
Profit after tax₹4 cr
Net debt (standalone)₹680 cr
Net debt (consolidated)₹1,175 cr
Insurance claims received (9M FY26)₹83.48 cr
Net insurance claim receivable₹251.12 cr
FY27 battery chemicals revenue guidance₹400–500 cr, management confirmed no change
Dahej replacement plant commissioning timelineQ1 FY27
Dahej salt capacity addition (1,100 tons) timelineMarch 2026, slipped from December 2025
Pakhajan electrolyte commercial production timelineH1 FY27
Pakhajan electrolyte salt commercial production timelineH2 FY27
Promoter preferential issue approvedUp to ₹150 cr, subject to regulatory approvals
Promoter stake51.22%
Morita investment in JV$20 mn for 20% stake; Neogen holds 80%
Expected total inflows by Q1 FY27 (insurance, Morita, promoter)~₹550 cr
India battery cell capacity expected online in current calendar year~12 GWh from Ola, Exide, Waaree Energy
India battery cell capacity estimate by end of 202740–50 GWh-plus entering 2028, if everything goes well
Neogen electrolyte capacity30 GWh worth of capacity ready
Total salt capacity at Pakhajan5,500 tons; at 80% utilization, ~4,400 tons at $20-plus average price implies ₹1,000 cr-plus revenue potential
Pakhajan electrolyte capacity30,000 MT annual, three lines, ~2,500 tons monthly
Salt capacity utilization ceiling80%
Electrolyte capacity utilization ceilingUp to 100%
Current revenue run rate₹800 cr-plus
Expected quarterly run rate in FY27₹225–250 cr
Expected FY27 revenue~₹950 cr